Home
Conditions
Hepatitis C, Chronic

Clinical trial condition

Hepatitis C, Chronic

Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.

699 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C, Chronic trial results

Completed

Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C

NCT03453346

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Chinese PLA 302 Hospital Beijing, Beijing Municipality, China

Peking University People's Hospital Beijing, Beijing Municipality, China

Capital Medical University Affiliated Beijing Youyi Hospital Beijing, Beijing Municipality, China

Capital Medical University Affiliated Beijing You'an Hospital Beijing, Beijing Municipality, China

View all 17 locations

View Trial Details

Completed

An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C

NCT01679834

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Hanover, Germany

Herne, Germany

View Trial Details

Completed

A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection

NCT02068222

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C

NCT03416491

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

Capital Medical University Affiliated Beijing Youyi Hospital Beijing, Beijing Municipality, China

Capital Medical University Affiliated Beijing You'an Hospital Beijing, Beijing Municipality, China

Chinese PLA Third Military Medical University First Affiliated Hospital Chongqing, Chongqing Municipality, China

View Trial Details

Completed

A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

NCT02356562

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C

NCT01790100

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Arensia, Republican Clinical Hospital Chisinau, Moldova

View Trial Details

Completed

Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

NCT01439373

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: GSK Investigational Site Anaheim, California, United States

GSK Investigational Site Chula Vista, California, United States

GSK Investigational Site Coronado, California, United States

GSK Investigational Site La Mesa, California, United States

View Trial Details

Completed

A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study

NCT01773070

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Side Effects After Direct-acting Antiviral Treatment

NCT03346941

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Croix-Rousse Hospital, Hospices Civils de Lyon Lyon, France

View Trial Details

Completed

Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy

NCT03348059

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Croix-Rousse Hospital, Hospices Civils de Lyon Lyon, France

View Trial Details

Hepatitis C, Chronic

Hepatitis C, Chronic trial results

Related conditions